Literature DB >> 12419707

Functions of the orexinergic/hypocretinergic system.

Jyrki P Kukkonen1, Tomas Holmqvist, Sylwia Ammoun, Karl E O Akerman.   

Abstract

Orexin A and orexin B are hypothalamic peptides that act on their targets via two G protein-coupled receptors (OX1 and OX2 receptors). In the central nervous system, the cell bodies producing orexins are localized in a narrow region within the lateral hypothalamus and project mainly to regions involved in feeding, sleep, and autonomic functions. Via putative pre- and postsynaptic effects, orexins increase synaptic activity in these regions. In isolated neurons and cells expressing recombinant receptors orexins cause Ca2+ elevation, which is mainly dependent on influx. The activity of orexinergic cells appears to be controlled by feeding- and sleep-related signals via a variety of neurotransmitters/hormones from the brain and other tissues. Orexins and orexin receptors are also found outside the central nervous system, particularly in organs involved in feeding and energy metabolism, e.g., gastrointestinal tract, pancreas, and adrenal gland. In the present review we focus on the physiological properties of the cells that secrete or respond to orexins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419707     DOI: 10.1152/ajpcell.00055.2002

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  48 in total

1.  Nitric oxide production in the perifornical-lateral hypothalamic area and its influences on the modulation of perifornical-lateral hypothalamic area neurons.

Authors:  A Kostin; S Rai; S Kumar; R Szymusiak; D McGinty; M N Alam
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

2.  [Narcoleptic dogs. Significance for human narcolepsy].

Authors:  J Schiefer
Journal:  Nervenarzt       Date:  2003-12       Impact factor: 1.214

3.  Regulation of OX1 orexin/hypocretin receptor-coupling to phospholipase C by Ca2+ influx.

Authors:  L Johansson; M E Ekholm; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2006-11-20       Impact factor: 8.739

4.  Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptor.

Authors:  David A Perrey; Nadezhda A German; Ann M Decker; David Thorn; Jun-Xu Li; Brian P Gilmour; Brian F Thomas; Danni L Harris; Scott P Runyon; Yanan Zhang
Journal:  ACS Chem Neurosci       Date:  2015-02-12       Impact factor: 4.418

Review 5.  Waking with the hypothalamus.

Authors:  Helmut L Haas; Jian-Sheng Lin
Journal:  Pflugers Arch       Date:  2011-07-28       Impact factor: 3.657

6.  The Treatment of Narcolepsy With Amphetamine-Based Stimulant Medications: A Call for Better Understanding.

Authors:  Moshe Turner
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

7.  Hindbrain Catecholamine Neurons Activate Orexin Neurons During Systemic Glucoprivation in Male Rats.

Authors:  Ai-Jun Li; Qing Wang; Megan M Elsarelli; R Lane Brown; Sue Ritter
Journal:  Endocrinology       Date:  2015-05-15       Impact factor: 4.736

8.  Arachidonic acid release mediated by OX1 orexin receptors.

Authors:  Pauli M Turunen; Marie E Ekholm; Pentti Somerharju; Jyrki P Kukkonen
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

9.  Orexin-1 receptor co-localizes with pancreatic hormones in islet cells and modulates the outcome of streptozotocin-induced diabetes mellitus.

Authors:  Ernest Adeghate; Maria Fernandez-Cabezudo; Rashed Hameed; Hussain El-Hasasna; Mohamed El Wasila; Tariq Abbas; Basel Al-Ramadi
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

10.  Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis.

Authors:  A Nuñez; M L Rodrigo-Angulo; I De Andrés; M Garzón
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.